Published in Clin Endocrinol (Oxf) on September 02, 2008
Idiopathic intracranial hypertension; research progress and emerging themes. J Neurol (2013) 0.91
Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol (2013) 0.84
Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry (2016) 0.84
An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics. Pediatr Res (2014) 0.81
Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. J Neurol (2010) 0.80
Is cerebrospinal fluid leptin altered in idiopathic intracranial hypertension? Clin Endocrinol (Oxf) (2009) 0.77
IL-1β, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls. Clin Endocrinol (Oxf) (2009) 0.77
Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases. J Pain Res (2016) 0.75
Over-drainage and persistent shunt-dependency in patients with idiopathic intracranial hypertension treated with shunts and bariatric surgery. Surg Neurol Int (2015) 0.75
Osmolality of Cerebrospinal Fluid from Patients with Idiopathic Intracranial Hypertension (IIH). PLoS One (2016) 0.75
Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults. J Neurol (2017) 0.75
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 6.21
Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ (2012) 5.28
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab (2001) 4.47
Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet (2001) 4.14
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Capsulorhexis phymosis following uncomplicated phacoemulsification surgery. Eye (Lond) (1997) 2.76
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) (1998) 2.59
The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry (2001) 2.57
Pathogenesis of non-alcoholic fatty liver disease. QJM (2009) 2.50
Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med (2009) 2.38
Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry (2001) 2.35
Does central obesity reflect "Cushing's disease of the omentum"? Lancet (1997) 2.34
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2010) 2.28
A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J (1989) 2.21
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab (2011) 2.16
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol (2000) 2.16
Cloning and expression of a distinctive class of self-incompatibility (S) gene from Papaver rhoeas L. Proc Natl Acad Sci U S A (1994) 2.15
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain (2000) 2.11
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet (1988) 1.97
Plasma lipids in human linoleic acid deficiency. Nutr Metab (1971) 1.91
Relapse of depression in primary care. Rate and clinical predictors. Arch Fam Med (1998) 1.87
Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis (2008) 1.86
Achieving guidelines for the treatment of depression in primary care: is physician education enough? Med Care (1997) 1.81
Modifying the request behaviour of clinicians. J Clin Pathol (1992) 1.78
A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res (1998) 1.78
Can enhanced acute-phase treatment of depression improve long-term outcomes? A report of randomized trials in primary care. Am J Psychiatry (1999) 1.77
Antioxidant capacity after acute ischaemic stroke. QJM (2002) 1.75
Improving the care of elderly diabetic patients: the final report of the St Vincent Joint Task Force for Diabetes. Age Ageing (1997) 1.67
Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol (2001) 1.66
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience (1989) 1.64
Medically unexplained symptoms in primary care. J Clin Psychiatry (1998) 1.64
Rate of progression of lung function impairment in alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.61
Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23%) diet and a 35% fat diet high in monounsaturated fat. Am J Clin Nutr (1996) 1.60
Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum (2001) 1.59
The inpatient neurology consultation service: value and cost. Clin Med (2011) 1.56
Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1992) 1.56
Effect of educational feedback on clinicians' requesting of cardiac enzymes. Ann Clin Biochem (1992) 1.55
Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int J Obes (Lond) (2008) 1.54
Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease. Lancet (1999) 1.52
Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene (1993) 1.51
Protein repletion and treatment in anorexia nervosa. Am J Clin Nutr (1994) 1.50
Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation (1998) 1.49
Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol (1999) 1.47
The future of geriatrics--a new horizon or a false dawn? J Nutr Health Aging (2006) 1.45
Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clin Endocrinol (Oxf) (1995) 1.44
Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids (1996) 1.44
A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet. J Am Diet Assoc (1997) 1.44
Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis (2008) 1.42
Depression after childbirth. J Am Board Fam Pract (1992) 1.42
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
Special needs of elderly diabetic patients. BMJ (1993) 1.39
Feedback of laboratory usage and cost data to clinicians: does it alter requesting behaviour? Ann Clin Biochem (1991) 1.39
Diagnosis and treatment of thyroid nodules and goitre. J R Coll Physicians Lond (1998) 1.38
Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med (2010) 1.35
The effects of supporting discharge from hospital to home in older people. Age Ageing (2000) 1.30
1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol (2000) 1.30
Improving prescribing using a rule based prescribing system. Qual Saf Health Care (2004) 1.29
Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology (1999) 1.29
The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. Am J Public Health (1999) 1.28
Assessing the ethical costs and benefits of trauma-focused research. Gen Hosp Psychiatry (1999) 1.27
Short term regulation of ureagenesis. J Biol Chem (1980) 1.26
Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy (2006) 1.24
Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology (2001) 1.24
Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) (1996) 1.23
Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab (1998) 1.23
Strain variation in Epstein-Barr virus immediate early genes. Virology (1993) 1.23
Ophthalmic referral rates for patients with diabetes in primary-care clinics located in disadvantaged urban communities. J Diabetes Complications (1995) 1.22
A comparison of physiotherapy techniques for patients with Parkinson's disease. Cochrane Database Syst Rev (2001) 1.21
Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab (2001) 1.21
Internal jugular phlebectasia. A clinicoroentgenographic diagnosis. Arch Otolaryngol (1976) 1.19
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab (2002) 1.18
11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod (1998) 1.18
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab (2004) 1.18
Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab (2002) 1.17
Dominant optic atrophy, Kjer type. Linkage analysis and clinical features in a large British pedigree. Arch Ophthalmol (1997) 1.16
Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin. Rheumatology (Oxford) (2008) 1.16
The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem Biophys Res Commun (2002) 1.15
Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab (1998) 1.13
Recognition and successful management in pulmonary aspergillosis in leukemia. Cancer (1978) 1.13
Glucocorticoid activity, inactivity and the osteoblast. J Endocrinol (1999) 1.11
Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res (2001) 1.11
Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells. Oncogene (1996) 1.11
Internal jugular phlebectasis. A clinicoroentgenographic diagnosis. Arch Otolaryngol (1976) 1.09
Blepharokeratoconjunctivitis in children: diagnosis and treatment. Br J Ophthalmol (2005) 1.09
Home administration of lanreotide Autogel by patients with acromegaly, or their partners, is safe and effective. Clin Endocrinol (Oxf) (2007) 1.09
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. Eur J Neurol (2005) 1.09
Designing clinical trials for the treatment of medically unexplained physical symptoms. J Psychosom Res (1998) 1.09
Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury. Brain Behav Immun (2009) 1.08
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood (1998) 1.08
Pituitary surgery for acromegaly. Should be done by specialists. BMJ (1999) 1.08
Nutrition, ageing and ill health. Br J Nutr (1998) 1.08
Depression and self-reported physical health in patients with coronary disease: mediating and moderating factors. Psychosom Med (2001) 1.08
Failure of the normal ureagenic response to amino acids in organic acid-loaded rats. Proposed mechanism for the hyperammonemia of propionic and methylmalonic acidemia. J Clin Invest (1980) 1.07
11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets. Diabetologia (2008) 1.07